Wrap (WRAP) 10-Q 10 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 10, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	000-55838
Entity Registrant Name	Wrap Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-0551945
Entity Address, Address Line One	1817 W 4th Street
Entity Address, City or Town	Tempe
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85281
City Area Code	800
Local Phone Number	583-2652
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	WRAP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		41,663,868
Entity Central Index Key	0001702924
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 9,503	$ 5,330
Short-term investments	6,500	13,949
Accounts receivable and contract assets, net	1,151	2,830
Inventories, net	5,626	3,975
Prepaid expenses and other current assets	858	775
Total current assets	23,638	26,859
Property and equipment, net	655	758
Operating lease right-of-use asset, net	259	285
Intangible assets, net	2,618	2,569
Other assets	70	100
Total assets	27,240	30,571
Current liabilities:
Accounts payable	1,376	1,419
Accrued liabilities	1,736	1,463
Customer deposits	1	0
Deferred revenue- short term	169	166
Operating lease liability - short term	111	108
Total current liabilities	3,393	3,156
Long-term liabilities:
Deferred revenue- long term	122	167
Operating lease liability - long term	164	193
Total long-term liabilities	286	360
Total liabilities	3,679	3,516
Stockholders' equity:
Preferred stock - 5,000,000 authorized; par value $0.0001 per share; none issued and outstanding	0	0
Common stock - 150,000,000 authorized; par value $0.0001 per share; 41,270,300 and 41,175,993 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	4	4
Additional paid-in capital	94,961	94,333
Accumulated deficit	(71,404)	(67,376)
Accumulated other comprehensive loss	0	94
Total stockholders' equity	23,561	27,055
Total liabilities and stockholders' equity	$ 27,240	$ 30,571

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)	41,270,300	41,175,993
Common stock, shares outstanding (in shares)	41,270,300	41,175,993

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Product sales	$ 616	$ 1,462
Other revenue	95	137
Total revenues	711	1,599
Cost of revenues	359	932
Gross profit	352	667
Operating expenses:
Selling, general and administrative	3,540	4,606
Research and development	1,072	1,495
Total operating expenses	4,612	6,101
Loss from operations	(4,260)	(5,434)
Other income (expense):
Interest income	236	2
Other	(4)	0
Nonoperating Income (Expense)	232	2
Net loss	$ (4,028)	$ (5,432)
Earnings Per Share, Basic	$ (0.10)	$ (0.13)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares)	41,415,808	40,907,266
Comprehensive loss:
Net loss	$ (4,028)	$ (5,432)
Net unrealized gain (loss) on short-term investments	0	(23)
Comprehensive loss	$ (4,028)	$ (5,455)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2021	40,851,945
Balance at Dec. 31, 2021	$ 4,000	$ 91,025,000	$ (49,759,000)	$ (6,000)	$ 41,264,000
Common shares issued upon exercise of stock options (in shares)	50,000
Common shares issued upon exercise of stock options	$ 0	75,000	0	0	75,000
Share-based compensation expense	$ 0	1,029,000	0	0	1,029,000
Common shares issued upon vesting of restricted stock units (in shares)	49,252
Net loss	$ 0	0	(5,432,000)	0	(5,432,000)
Net unrealized gain (loss) on short-term investments	0	0	0	(23,000)	(23,000)
Net loss for the period	$ 0	0	(5,432,000)	0	(5,432,000)
Balance (in shares) at Mar. 31, 2022	40,951,197
Balance at Mar. 31, 2022	$ 4,000	92,129,000	(55,191,000)	(29,000)	36,913,000
Balance (in shares) at Dec. 31, 2022	41,175,993
Balance at Dec. 31, 2022	$ 4,000	94,333,000	(67,376,000)	94,000	$ 27,055,000
Common shares issued upon exercise of stock options (in shares)	250				250
Common shares issued upon exercise of stock options	$ 0	0	0	0	$ 0
Share-based compensation expense	$ 0	628,000	0	0	628,000
Common shares issued upon vesting of restricted stock units (in shares)	94,057
Common shares issued upon vesting of restricted stock units	$ 0	0	0	0	0
Settlement – US Treasury bills	0	0	0	(94,000)	(94,000)
Net loss	0	0	(4,028,000)	0	(4,028,000)
Net unrealized gain (loss) on short-term investments					0
Net loss for the period	$ 0	0	(4,028,000)	0	(4,028,000)
Balance (in shares) at Mar. 31, 2023	41,270,300
Balance at Mar. 31, 2023	$ 4,000	$ 94,961,000	$ (71,404,000)	$ 0	$ 23,561,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows From Operating Activities:
Net loss	$ (4,028)	$ (5,432)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	200	183
Share-based compensation	628	1,209
Warranty provision	(33)	12
Non-cash lease expense	26	24
Provision for doubtful accounts	(8)	18
Changes in assets and liabilities:
Accounts receivable	1,687	(398)
Inventories	(1,652)	(304)
Prepaid expenses and other current assets	(83)	133
Accounts payable	(42)	(51)
Operating lease liability	(26)	(21)
Customer deposits	1	(43)
Accrued liabilities and other	306	37
Warranty settlement	(1)	(54)
Deferred revenue	(42)	17
Net cash used in operating activities	(3,067)	(4,850)
Cash Flows From Investing Activities:
Purchase of short-term investments	(2,645)	(4,996)
Proceeds from maturities of short-term investments	10,000	10,000
Capital expenditures for property and equipment	(15)	(81)
Investment in long-term deposits	0	(2)
Proceeds from long-term deposits	31	0
Net cash provided by investing activities	7,240	4,852
Cash Flows From Financing Activities:
Proceeds from exercise of stock options	0	75
Net cash provided by financing activities	0	75
Net decrease in cash and cash equivalents	4,173	77
Cash and cash equivalents, beginning of period	5,330	4,937
Cash and cash equivalents, end of period	9,503	5,014
Supplemental Disclosure of Non-Cash Investing
Change in unrealized gain on short-term investments	(94)	(23)
Right-of-use asset and liability recorded during period	0	335
Patents and Trademarks [Member]
Cash Flows From Investing Activities:
Investment in patents and trademarks	$ (131)	$ (69)

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Business Description Wrap Technologies, Inc., a Delaware corporation (the “ Company we us our Common Stock Nasdaq Basis of Presentation The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“ SEC U.S. GAAP Annual Report Where necessary, the prior year’s information has been reclassified to conform to the current year presentation. Principles of Consolidation The Company has one VR Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates. Loss per Share Basic loss per common share is computed by dividing net loss for the period by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net loss per Common Share reflects the potential dilution of securities that could share in the earnings of an entity. The Company’s losses for the periods presented cause the inclusion of potential Common Stock instruments outstanding to be antidilutive. Stock options and restricted stock units exercisable or issuable for a total of 5,127,830 and 5,350,111 shares of Common Stock were outstanding at March 31, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company. Recent Issued Accounting Guidance The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

Note 2 - Revenue and Product Co

Note 2 - Revenue and Product Costs	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	2. REVENUE AND PRODUCT COSTS Revenue consists of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenues, service, training and shipping revenues. The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the three months ended March 31, 2023. Customer Deferred Deposits Revenue Balance at January 1, 2023 $ - $ 333 Additions, net 1 30 Transfer to revenue - (72 ) Balance at March 31, 2023 $ 1 $ 291 Current portion $ 1 $ 169 Long-term portion $ - $ 122 At March 31, 2023, the Company’s deferred revenue of $291 consisted of $175 related to VR and $10 related to training and $106 related to BolaWrap extended warranties and services. At December 31, 2022, the Company’s deferred revenue of $333 consisted of $198 related to VR, $11 related to training and $124 related to BolaWrap extended warranties and services. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract. Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to cost of products sold.

Note 3 - Financial Instruments

Note 3 - Financial Instruments	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Fair Value Disclosures [Text Block]	3. FINANCIAL INSTRUMENTS Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: Level 1 Level 2 Level 3 The Company’s cash equivalent Money Market Funds and short-term investments consisting of U.S. Treasury bill securities and Certificate of Deposits are classified as Level I because they are valued using quoted market prices. The following table shows the Company’s cash and cash equivalents, Money Market Funds and short-term investments by significant investment category as of March 31, 2023, and December 31, 2022. As of March 31, 2023 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 2,764 $ - $ - $ 2,764 U.S. Treasury securities in short-term investments - - - - Certificate of Deposits 6,500 - - 6,500 Total Financial Assets $ 9,264 $ - $ - $ 9,264 As of December 31, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,004 $ - $ - $ 3,004 U.S. Treasury securities in short-term investments 9,849 100 - 9,949 Certificate of Deposits 4,000 - - 4,000 Total Financial Assets $ 16,853 $ - $ - $ 16,953 Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss as they are classified as available for sale. During the three months ended March 31, 2023 and 2022, a $0 and $ (23) Our financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

Note 4 - Inventories, Net

Note 4 - Inventories, Net	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. INVENTORIES, NET Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following: March 31, 2023 December 31, 2022 Finished goods $ 3,717 $ 2,293 Work in process - - Raw materials 1,909 1,682 Inventories - net $ 5,626 $ 3,975

Note 5 - Property and Equipment

Note 5 - Property and Equipment, Net	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	5. PROPERTY AND EQUIPMENT, NET Property and equipment consisted of the following: March 31, 2023 December 31, 2022 Production and lab equipment $ 503 $ 513 Tooling 451 448 Computer equipment 553 531 Furniture, fixtures and improvements 181 181 1,688 1,673 Accumulated depreciation (1,033 ) (915 ) Property and equipment, net $ 655 $ 758 Depreciation expense was $118 and $113 for the three months ended March 31, 2023 and 2022, respectively.

Note 6 - Intangible Assets, Net

Note 6 - Intangible Assets, Net	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	6. INTANGIBLE ASSETS, NET Intangible assets consisted of the following: March 31, 2023 December 31, 2022 Amortizable intangible assets: Patents $ 701 $ 575 Trademarks 155 150 Purchased software 1,962 1,962 2,818 2,687 Accumulated amortization (544 ) (462 ) Total amortizable 2,274 2,225 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 2,618 $ 2,569 Amortization expense was $82 and $70 for the three months ended March 31, 2023 and 2022, respectively. At March 31, 2023, future amortization expense is as follows: 2023 (9 months) $ 330 2024 518 2025 513 2026 309 2027 42 Thereafter 562 Total estimated amortization expense $ 2,274

Note 7 - Accounts Payable and A

Note 7 - Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	7. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payable includes $24 and $127 due to related party Syzygy Licensing, LLC (“ Syzygy Accrued liabilities consist of the following: March 31, 2023 December 31, 2022 Patent and legal costs $ 129 $ 135 Accrued compensation 1,352 1,100 Warranty costs 91 125 Taxes and other 164 103 $ 1,736 $ 1,463 Accrued compensation includes $1,005 and $1,022 in employee bonuses and commissions payable at March 31, 2023 and December 31, 2022, respectively. Changes in our estimated product warranty costs were as follows: Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 125 $ 96 Warranty settlements (1 ) (54 ) Warranty provision (33 ) 12 Balance, end of period $ 91 $ 54

Note 8 - Stockholders' Equity

Note 8 - Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Equity [Text Block]	8. STOCKHOLDERS' EQUITY The Company’s authorized capital consists of 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share (“ Preferred Stock

Note 9 - Share-based Compensati

Note 9 - Share-based Compensation	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	9. SHARE-BASED COMPENSATION On March 31, 2017 , Plan , The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan. Stock Options The following table summarizes stock option activity for the three months ended March 31, 2023: Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2023 5,491,399 $ 3.72 5.96 $ 92 Granted - $ 0 Exercised (250 ) $ 1.50 Forfeited, cancelled, expired (1,300,287 ) $ 5.33 Outstanding March 31, 2023 4,190,862 $ 3.15 7.49 $ 98 Exercisable March 31, 2023 1,299,771 $ 3.74 4.11 $ 96 At March 31, 2023, there were 2,576,632 service-based stock options outstanding, and 1,614,230 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,049,145 of the 4,190,862 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant, but are subject to the terms and conditions of the Plan. The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees: For the Three Months Ended March 31, 2023 2022 Expected stock price volatility 0 % 49 % Risk-free interest rate 0 % 1.57 % Expected dividend yield 0 % 0 % Expected life of options - years 0 1.39 Weighted-average fair value of options granted $ 0 $ 1.72 Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred. The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. Stock option expense was $313 and $737 for the three months ended March 31, 2023 and 2022, respectively. Restricted Stock Units The Plan provides for the grant of restricted stock units (“ RSUs Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2023 922,057 $ 2.88 2.11 Granted - service based 124,862 $ 1.84 Vested (106,565 ) $ 2.87 Forfeited and cancelled (3,386 ) $ 5.52 Unvested at March 31, 2023 936,968 $ 2.56 1.99 RSU expense was $315 and $291 for the three months ended March 31, 2023 and 2022, respectively. Share-Based Compensation Expense The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows: Three Months Ended March 31, 2023 2022 Selling, general and administrative $ 562 $ 894 Research and development 66 135 Total share-based expense $ 628 $ 1,029 As of March 31, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $3,061 which is expected to be recognized over the weighted average period of 3.23 years. As of March 31, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $1,700 which is expected to be recognized over the weighted average period of 1.99 years.

Note 10 - Defined Contribution

Note 10 - Defined Contribution Plan	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Defined Contribution Plan [Text Block]	10. DEFINED CONTRIBUTION PLAN The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for the three months ended March 31, 2023 and year ended December 31, 2022 was $0 respectively.

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	11. COMMITMENTS AND CONTINGENCIES Related Party Technology License Agreement The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026 , Service Provider Agreement Pursuant to the Professional Services and Technology Acquisition Agreement (the “ Agreement Service Provider Technology, Services, and License Purchase Commitments At March 31, 2023, the Company was committed for approximately $3,493 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business. Indemnifications and Guarantees Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities. Regulatory Agencies The Company is subject to oversight from regulatory agencies regarding firearms that arises in the ordinary course of its business. Litigation Shareholder Derivative Litigation On November 13, 2020, Naresh Rammohan filed a shareholder derivative action in the US District Court for the Central District of California against current and former Company officers as well as current and former Company directors alleging unjust enrichment, breach of fiduciary duty, waste of corporate assets, and contribution claims under the Securities Exchange Act of 1934, docketed as Case No. 2:20-cv-10444-DMG-PVCx. The derivative action was dismissed with prejudice by stipulation of the parties on May 3, 2022.

Note 12 - Related Party Transac

Note 12 - Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	12. RELATED PARTY TRANSACTIONS Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer and current stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $4.5 during the three months ended March 31, 2023, and 2022, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective June 30, 2021, and commencing July 1, 2021, was engaged as a month-to-month consultant. A greater than 10% stockholder, Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $22.5 during each of the three months ended March 31, 2023 and 2022. See Notes 7 and 11 for additional information on related party transactions and obligations.

Note 13 - Major Customers and R

Note 13 - Major Customers and Related Information	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	13. MAJOR CUSTOMERS AND RELATED INFORMATION For the three months ended March 31, 2023, revenues from two two At March 31, 2023, accounts receivable from one one The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’s delivery location: For the Three Months Ended March 31, 2023 2022 Americas $ 710 $ 1,194 Europe, Middle East and Africa 1 174 Asia Pacific 0 231 Total $ 711 $ 1,599

Note 14 - Subsequent Events

Note 14 - Subsequent Events	3 Months Ended
	Mar. 31, 2023
Notes to Financial Statements
Subsequent Events [Text Block]	14. SUBSEQUENT EVENTS On April 17, 2023, Kevin Mullins was named Chief Executive Officer. In connection with Mr. Mullins' appointment, TJ Kennedy agreed to immediately step down as the Company’s Chief Executive Officer and a member of the Board of Directors (the “ Board

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Organization and Business Description [Policy Text Block]	Organization and Business Description Company we us our Common Stock Nasdaq
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation SEC U.S. GAAP Annual Report
Consolidation, Policy [Policy Text Block]	Principles of Consolidation one VR
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
Earnings Per Share, Policy [Policy Text Block]	Loss per Share
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Issued Accounting Guidance

Note 2 - Revenue and Product _2

Note 2 - Revenue and Product Costs (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Customer Deferred Deposits Revenue Balance at January 1, 2023 $ - $ 333 Additions, net 1 30 Transfer to revenue - (72 ) Balance at March 31, 2023 $ 1 $ 291 Current portion $ 1 $ 169 Long-term portion $ - $ 122

Note 3 - Financial Instruments

Note 3 - Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	As of March 31, 2023 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 2,764 $ - $ - $ 2,764 U.S. Treasury securities in short-term investments - - - - Certificate of Deposits 6,500 - - 6,500 Total Financial Assets $ 9,264 $ - $ - $ 9,264 As of December 31, 2022 Adjusted Unrealized Unrealized Market Cost Gains Losses Value Level 1: Money Market Funds $ 3,004 $ - $ - $ 3,004 U.S. Treasury securities in short-term investments 9,849 100 - 9,949 Certificate of Deposits 4,000 - - 4,000 Total Financial Assets $ 16,853 $ - $ - $ 16,953

Note 4 - Inventories, Net (Tabl

Note 4 - Inventories, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	March 31, 2023 December 31, 2022 Finished goods $ 3,717 $ 2,293 Work in process - - Raw materials 1,909 1,682 Inventories - net $ 5,626 $ 3,975

Note 5 - Property and Equipme_2

Note 5 - Property and Equipment, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, 2023 December 31, 2022 Production and lab equipment $ 503 $ 513 Tooling 451 448 Computer equipment 553 531 Furniture, fixtures and improvements 181 181 1,688 1,673 Accumulated depreciation (1,033 ) (915 ) Property and equipment, net $ 655 $ 758

Note 6 - Intangible Assets, N_2

Note 6 - Intangible Assets, Net (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	March 31, 2023 December 31, 2022 Amortizable intangible assets: Patents $ 701 $ 575 Trademarks 155 150 Purchased software 1,962 1,962 2,818 2,687 Accumulated amortization (544 ) (462 ) Total amortizable 2,274 2,225 Indefinite life assets (non-amortizable) 344 344 Total intangible assets, net $ 2,618 $ 2,569
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2023 (9 months) $ 330 2024 518 2025 513 2026 309 2027 42 Thereafter 562 Total estimated amortization expense $ 2,274

Note 7 - Accounts Payable and_2

Note 7 - Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	March 31, 2023 December 31, 2022 Patent and legal costs $ 129 $ 135 Accrued compensation 1,352 1,100 Warranty costs 91 125 Taxes and other 164 103 $ 1,736 $ 1,463
Schedule of Product Warranty Liability [Table Text Block]	Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 125 $ 96 Warranty settlements (1 ) (54 ) Warranty provision (33 ) 12 Balance, end of period $ 91 $ 54

Note 9 - Share-based Compensa_2

Note 9 - Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Options on Remaining Aggregate Common Exercise Contractual Intrinsic Shares Price Term Value Outstanding January 1, 2023 5,491,399 $ 3.72 5.96 $ 92 Granted - $ 0 Exercised (250 ) $ 1.50 Forfeited, cancelled, expired (1,300,287 ) $ 5.33 Outstanding March 31, 2023 4,190,862 $ 3.15 7.49 $ 98 Exercisable March 31, 2023 1,299,771 $ 3.74 4.11 $ 96
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	For the Three Months Ended March 31, 2023 2022 Expected stock price volatility 0 % 49 % Risk-free interest rate 0 % 1.57 % Expected dividend yield 0 % 0 % Expected life of options - years 0 1.39 Weighted-average fair value of options granted $ 0 $ 1.72
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Weighted Average Weighted Average Service-Based Grant Date Vesting RSU's Fair Value Period (Years) Unvested at January 1, 2023 922,057 $ 2.88 2.11 Granted - service based 124,862 $ 1.84 Vested (106,565 ) $ 2.87 Forfeited and cancelled (3,386 ) $ 5.52 Unvested at March 31, 2023 936,968 $ 2.56 1.99
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Three Months Ended March 31, 2023 2022 Selling, general and administrative $ 562 $ 894 Research and development 66 135 Total share-based expense $ 628 $ 1,029

Note 13 - Major Customers and_2

Note 13 - Major Customers and Related Information (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the Three Months Ended March 31, 2023 2022 Americas $ 710 $ 1,194 Europe, Middle East and Africa 1 174 Asia Pacific 0 231 Total $ 711 $ 1,599

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended
	Mar. 31, 2023 $ / shares shares	Mar. 31, 2022 shares	Dec. 31, 2022 $ / shares
Common Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001		$ 0.0001
Number of Wholly-owned Subsidiaries	1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares	5,127,830	5,350,111

Note 2 - Revenue and Product _3

Note 2 - Revenue and Product Costs (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Contract with Customer, Liability	$ 291	$ 333
Virtual Reality Training [Member]
Contract with Customer, Liability	175	198
Training [Member]
Contract with Customer, Liability	10	11
Extended Product Warranties [Member]
Contract with Customer, Liability	$ 106	$ 124

Note 2 - Revenue and Product _4

Note 2 - Revenue and Product Costs - Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Balance at January 1, 2023	$ 333
Balance at March 31, 2023	291
Current portion	169	$ 166
Long-term portion	122	$ 167
Customer Deposits [Member]
Balance at January 1, 2023	0
Additions, net	1
Transfer to revenue	0
Balance at March 31, 2023	1
Current portion	1
Long-term portion	0
Deferred Revenue [Member]
Balance at January 1, 2023	333
Additions, net	30
Transfer to revenue	(72)
Balance at March 31, 2023	291
Current portion	169
Long-term portion	$ 122

Note 3 - Financial Instrument_2

Note 3 - Financial Instruments (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$ 0	$ (23)

Note 3 - Financial Instrument_3

Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) - Fair Value, Inputs, Level 1 [Member] - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Adjusted Cost	$ 9,264	$ 16,853
Unrealized Gains	0	0
Unrealized Losses	0	0
Market Value	9,264	16,953
Money Market Funds [Member]
Adjusted Cost	2,764	3,004
Unrealized Gains	0	0
Unrealized Losses	0	0
Market Value	2,764	3,004
US Treasury Securities in Short-term Investments [Member]
Adjusted Cost		9,849
Unrealized Gains		100
Unrealized Losses		0
Market Value		9,949
Certificates of Deposit [Member]
Adjusted Cost	6,500	4,000
Unrealized Gains	0	0
Unrealized Losses	0	0
Market Value	6,500	$ 4,000
US Treasury Securities Considered Cash Equivalents [Member]
Unrealized Gains	0
Unrealized Losses	$ 0

Note 4 - Inventories, Net - Sum

Note 4 - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Finished goods	$ 3,717	$ 2,293
Work in process	0	0
Raw materials	1,909	1,682
Inventories - net	$ 5,626	$ 3,975

Note 5 - Property and Equipme_3

Note 5 - Property and Equipment, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Depreciation	$ 118	$ 113

Note 5 - Property and Equipme_4

Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property and equipment, gross	$ 1,688	$ 1,673
Accumulated depreciation	(1,033)	(915)
Property and equipment, net	655	758
Production and Lab Equipment [Member]
Property and equipment, gross	503	513
Tooling [Member]
Property and equipment, gross	451	448
Computer Equipment [Member]
Property and equipment, gross	553	531
Furniture and Fixtures [Member]
Property and equipment, gross	$ 181	$ 181

Note 6 - Intangible Assets, N_3

Note 6 - Intangible Assets, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Amortization of Intangible Assets	$ 82	$ 70

Note 6 - Intangible Assets, N_4

Note 6 - Intangible Assets, Net - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Amortizable intangible assets, gross	$ 2,818	$ 2,687
Accumulated amortization	(544)	(462)
Total amortizable	2,274	2,225
Indefinite life assets (non-amortizable)	344	344
Total intangible assets, net	2,618	2,569
Patents [Member]
Amortizable intangible assets, gross	701	575
Trademarks [Member]
Amortizable intangible assets, gross	155	150
Computer Software, Intangible Asset [Member]
Amortizable intangible assets, gross	$ 1,962	$ 1,962

Note 6 - Intangible Assets, N_5

Note 6 - Intangible Assets, Net - Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
2023 (9 months)	$ 330
2024	518
2025	513
2026	309
2027	42
Thereafter	562
Total amortizable	$ 2,274	$ 2,225

Note 7 - Accounts Payable and_3

Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Former CEO Payable [Member]
Employee-related Liabilities	$ 1,005
Commissions Payable [Member]
Employee-related Liabilities		$ 1,022
Syzygy Licensing LLC [Member]
Accounts Payable	$ 24	$ 127

Note 7 - Accounts Payable and_4

Note 7 - Accounts Payable and Accrued Liabilities - Summary of Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Patent and legal costs	$ 129	$ 135
Accrued compensation	1,352	1,100
Warranty costs	91	125
Taxes and other	164	103
Accrued Liabilities, Current	$ 1,736	$ 1,463

Note 7 - Accounts Payable and_5

Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Balance, beginning of period	$ 125	$ 96
Warranty settlements	(1)	(54)
Warranty provision	(33)	12
Balance, end of period	$ 91	$ 54

Note 8 - Stockholders' Equity (

Note 8 - Stockholders' Equity (Details Textual) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Common Stock, Shares Authorized	150,000,000	150,000,000
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001

Note 9 - Share-based Compensa_3

Note 9 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended						3 Months Ended
	Jun. 30, 2022	Apr. 30, 2022	Jan. 31, 2022	Jun. 30, 2021	Jun. 30, 2020	May 31, 2019	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Mar. 31, 2017
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number							4,190,862		5,491,399
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross							0
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate							0%
Share-Based Payment Arrangement, Expense							$ 628	$ 1,029
Performance Shares [Member] | Chief Executive Officer and President [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,049,145
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate							0%	0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term							0 years	1 year 4 months 20 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate								49%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate							0%	1.57%
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							$ 3,061
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition							3 years 2 months 23 days
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount							$ 1,700
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition							1 year 11 months 26 days
The 2017 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized	9,000,000									2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized	1,500,000			1,500,000	1,900,000	2,100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant							2,735,102
Share-Based Payment Arrangement, Accelerated Cost			$ 242
The 2017 Stock Incentive Plan [Member] | Service-based Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number							2,576,632
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number							1,614,230
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		1,614,230
Share Price		$ 2.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term		10 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		49%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		2.90%
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		4 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period		7 years
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 250,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		500,000
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization		$ 1,000,000
The 2017 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense							$ 313	$ 737
The 2017 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expense							$ 315	$ 291

Note 9 - Share-based Compensa_4

Note 9 - Share-based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Options on Common Shares, Outstanding (in shares)	5,491,399
Outstanding, weighted average exercise price (in dollars per share)	$ 3.72
Outstanding, remaining contractual term (Year)	7 years 5 months 26 days	5 years 11 months 15 days
Outstanding, aggregate intrinsic value	$ 98	$ 92
Options on Common Shares, Granted (in shares)	0
Granted, weighted average exercise price (in dollars per share)	$ 0
Options on Common Shares, Exercised (in shares)	(250)
Exercised, weighted average exercise price (in dollars per share)	$ 1.50
Options on Common Shares, Forfeited, cancelled, expired (in shares)	(1,300,287)
Forfeited, cancelled, expired, weighted average exercise price (in dollars per share)	$ 5.33
Options on Common Shares, Outstanding (in shares)	4,190,862	5,491,399
Outstanding, weighted average exercise price (in dollars per share)	$ 3.15	$ 3.72
Options on Common Shares, Exercisable (in shares)	1,299,771
Exercisable, weighted average exercise price (in dollars per share)	$ 3.74
Exercisable, remaining contractual term (Year)	4 years 1 month 9 days
Exercisable, aggregate intrinsic value	$ 96

Note 9 - Share-based Compensa_5

Note 9 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Expected stock price volatility	0%
Weighted-average fair value of options granted (in dollars per share)	$ 0	$ 1.72
Share-Based Payment Arrangement, Option [Member]
Expected stock price volatility		49%
Risk-free interest rate	0%	1.57%
Expected dividend yield	0%	0%
Expected life of options - years (Year)	0 years	1 year 4 months 20 days

Note 9 - Share-based Compensa_6

Note 9 - Share-based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Awards other than options, unvested, beginning balance (in shares)	922,057
Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share)	$ 2.88
Weighted average vesting period (Year)	1 year 11 months 26 days	2 years 1 month 9 days
Awards other than options, Granted (in shares)	124,862
Awards other than options, granted, weighted average grant date fair value (in dollars per share)	$ 1.84
Awards other than options, Vested (in shares)	(106,565)
Awards other than options, vested, weighted average grant date fair value (in dollars per share)	$ 2.87
Awards other than options, Forfeited and cancelled (in shares)	(3,386)
Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share)	$ 5.52
Awards other than options, unvested, ending balance (in shares)	936,968	922,057
Awards other than options, unvested, weighted average grant date fair value, ending balance (in dollars per share)	$ 2.56	$ 2.88

Note 9 - Share-based Compensa_7

Note 9 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based expense	$ 628	$ 1,029
Selling, General and Administrative Expenses [Member]
Share-based expense	562	894
Research and Development Expense [Member]
Share-based expense	$ 66	$ 135

Note 10 - Defined Contributio_2

Note 10 - Defined Contribution Plan (Details Textual) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 0	$ 0

Note 11 - Commitments and Con_2

Note 11 - Commitments and Contingencies (Details Textual) - USD ($)		3 Months Ended
	Nov. 22, 2022	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2016
Contractual Obligation		$ 3,493,000
Professional Services and Technology Acquisition Agreement [Member]
Payments to Acquire Businesses, Gross	$ 700,000
Related Party Technology License Agreement [Member] | Syzygy Licensing LLC [Member]
Royalty Payments, Percentage of Product Revenue				4%
Maximum Royalties to Be Paid Under Agreement				$ 1,000
Royalty Expense		24,000	$ 49,000
Royalty Guarantees, Commitments, Amount		$ 257,000

Note 12 - Related Party Trans_2

Note 12 - Related Party Transactions (Details Textual)	3 Months Ended
	Mar. 31, 2023 USD ($)
Related Party Transaction, Amounts of Transaction	$ 4,500
Mr. Elwood Norris [Member]
Reimbursement of Expenses to Related Party, Monthly Amount	1,500
Consulting Fees to Related Party, Monthly Amount	7,500
Mr. Elwood Norris [Member] | Consultant [Member]
Related Party Transaction, Amounts of Transaction	$ 22,500

Note 13 - Major Customers and_3

Note 13 - Major Customers and Related Information (Details Textual) - Customer Concentration Risk [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenue Benchmark [Member] | Distributors [Member]
Number of Major Customers	1	2
Revenue Benchmark [Member] | Distributor One [Member]
Concentration Risk, Percentage	28%	25%
Revenue Benchmark [Member] | Distributor Two [Member]
Concentration Risk, Percentage	15%	14%
Accounts Receivable [Member] | Distributors [Member]
Number of Major Customers	2		3
Accounts Receivable [Member] | Distributor One [Member]
Concentration Risk, Percentage	41%		70%

Note 13 - Major Customers and_4

Note 13 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues	$ 711	$ 1,599
Americas [Member]
Revenues	710	1,194
Europe, Middle East and Africa [Member]
Revenues	1	174
Asia Pacific [Member]
Revenues	$ 0	$ 231